XERS logo

Xeris Biopharma Holdings, Inc. (XERS) Revenue

Annual revenue:

$203.07M+$39.16M(+23.89%)
December 31, 2024

Summary

  • As of today (September 16, 2025), XERS annual revenue is $203.07 million, with the most recent change of +$39.16 million (+23.89%) on December 31, 2024.
  • During the last 3 years, XERS annual revenue has risen by +$153.48 million (+309.50%).
  • XERS annual revenue is now at all-time high.

Performance

XERS Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherXERSincome statement metrics

Quarterly revenue:

$71.54M+$11.42M(+19.00%)
June 30, 2025

Summary

  • As of today (September 16, 2025), XERS quarterly revenue is $71.54 million, with the most recent change of +$11.42 million (+19.00%) on June 30, 2025.
  • Over the past year, XERS quarterly revenue has increased by +$23.47 million (+48.84%).
  • XERS quarterly revenue is now at all-time high.

Performance

XERS Quarterly revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherXERSincome statement metrics

TTM revenue:

$246.03M+$23.47M(+10.55%)
June 30, 2025

Summary

  • As of today (September 16, 2025), XERS TTM revenue is $246.03 million, with the most recent change of +$23.47 million (+10.55%) on June 30, 2025.
  • Over the past year, XERS TTM revenue has increased by +$64.61 million (+35.62%).
  • XERS TTM revenue is now at all-time high.

Performance

XERS TTM revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherXERSincome statement metrics

XERS Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+23.9%+48.8%+35.6%
3 y3 years+309.5%+182.7%+208.0%
5 y5 years+7360.3%+3429.3%+4005.9%

XERS Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+309.5%at high+182.7%at high+208.0%
5 y5-yearat high+7360.3%at high+3429.3%at high+4005.9%
alltimeall timeat high>+9999.0%at high>+9999.0%at high>+9999.0%

XERS Revenue History

DateAnnualQuarterlyTTM
Jun 2025
-
$71.54M(+19.0%)
$246.03M(+10.5%)
Mar 2025
-
$60.12M(+0.0%)
$222.55M(+9.6%)
Dec 2024
$203.07M(+23.9%)
$60.10M(+10.7%)
$203.07M(+8.4%)
Sep 2024
-
$54.27M(+12.9%)
$187.36M(+3.3%)
Jun 2024
-
$48.06M(+18.3%)
$181.41M(+5.9%)
Mar 2024
-
$40.64M(-8.5%)
$171.36M(+4.5%)
Dec 2023
$163.91M(+48.7%)
$44.39M(-8.1%)
$163.91M(+7.4%)
Sep 2023
-
$48.32M(+27.1%)
$152.67M(+13.9%)
Jun 2023
-
$38.01M(+14.5%)
$134.07M(+10.5%)
Mar 2023
-
$33.20M(+0.2%)
$121.37M(+10.1%)
Dec 2022
$110.25M(+122.3%)
$33.14M(+11.5%)
$110.25M(+11.9%)
Sep 2022
-
$29.73M(+17.5%)
$98.53M(+23.4%)
Jun 2022
-
$25.31M(+14.6%)
$79.87M(+25.8%)
Mar 2022
-
$22.07M(+3.0%)
$63.47M(+28.0%)
Dec 2021
$49.59M
$21.43M(+93.8%)
$49.59M(+40.4%)
Sep 2021
-
$11.06M(+24.2%)
$35.33M(+4.8%)
Jun 2021
-
$8.91M(+8.7%)
$33.72M(+25.6%)
DateAnnualQuarterlyTTM
Mar 2021
-
$8.20M(+14.3%)
$26.84M(+31.4%)
Dec 2020
$20.43M(+650.7%)
$7.17M(-24.1%)
$20.43M(+35.1%)
Sep 2020
-
$9.45M(+366.1%)
$15.13M(+152.5%)
Jun 2020
-
$2.03M(+13.4%)
$5.99M(+39.8%)
Mar 2020
-
$1.79M(-4.1%)
$4.29M(+56.1%)
Dec 2019
$2.72M(+12.3%)
$1.86M(+495.5%)
$2.75M(+63.2%)
Sep 2019
-
$313.00K(-2.2%)
$1.68M(-13.8%)
Jun 2019
-
$320.00K(+29.0%)
$1.95M(-20.4%)
Mar 2019
-
$248.00K(-69.0%)
$2.45M(-0.6%)
Dec 2018
$2.42M(+55.7%)
$801.00K(+37.6%)
$2.46M(+48.1%)
Sep 2018
-
$582.00K(-28.9%)
$1.66M(+32.9%)
Jun 2018
-
$819.00K(+211.4%)
$1.25M(+189.1%)
Mar 2018
-
$263.00K(+54.7%)
$433.00K(-17.4%)
Dec 2017
$1.56M(+44.7%)
-
-
Sep 2017
-
$170.00K(-52.0%)
$524.00K(+48.0%)
Mar 2017
-
$354.00K
$354.00K
Dec 2016
$1.07M
-
-

FAQ

  • What is Xeris Biopharma Holdings, Inc. annual revenue?
  • What is the all time high annual revenue for Xeris Biopharma Holdings, Inc.?
  • What is Xeris Biopharma Holdings, Inc. annual revenue year-on-year change?
  • What is Xeris Biopharma Holdings, Inc. quarterly revenue?
  • What is the all time high quarterly revenue for Xeris Biopharma Holdings, Inc.?
  • What is Xeris Biopharma Holdings, Inc. quarterly revenue year-on-year change?
  • What is Xeris Biopharma Holdings, Inc. TTM revenue?
  • What is the all time high TTM revenue for Xeris Biopharma Holdings, Inc.?
  • What is Xeris Biopharma Holdings, Inc. TTM revenue year-on-year change?

What is Xeris Biopharma Holdings, Inc. annual revenue?

The current annual revenue of XERS is $203.07M

What is the all time high annual revenue for Xeris Biopharma Holdings, Inc.?

Xeris Biopharma Holdings, Inc. all-time high annual revenue is $203.07M

What is Xeris Biopharma Holdings, Inc. annual revenue year-on-year change?

Over the past year, XERS annual revenue has changed by +$39.16M (+23.89%)

What is Xeris Biopharma Holdings, Inc. quarterly revenue?

The current quarterly revenue of XERS is $71.54M

What is the all time high quarterly revenue for Xeris Biopharma Holdings, Inc.?

Xeris Biopharma Holdings, Inc. all-time high quarterly revenue is $71.54M

What is Xeris Biopharma Holdings, Inc. quarterly revenue year-on-year change?

Over the past year, XERS quarterly revenue has changed by +$23.47M (+48.84%)

What is Xeris Biopharma Holdings, Inc. TTM revenue?

The current TTM revenue of XERS is $246.03M

What is the all time high TTM revenue for Xeris Biopharma Holdings, Inc.?

Xeris Biopharma Holdings, Inc. all-time high TTM revenue is $246.03M

What is Xeris Biopharma Holdings, Inc. TTM revenue year-on-year change?

Over the past year, XERS TTM revenue has changed by +$64.61M (+35.62%)
On this page